Editorial: Cancer Care Delivery and Women’s Health: Beyond the Patient and Provider Relationship

Por Temkin, Sarah M.
Publicado no Front Oncol (2017)

The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?

Por Temkin, Sarah M., Minasian, Lori, Noone, Anne-Michelle
Publicado no Front Oncol (2016)

Ovarian cancer prevention in high risk women

Por Temkin, Sarah M., Bergstrom, Jennifer, Samimi, Goli, Minasian, Lori
Publicado no Clin Obstet Gynecol (2017)

Black and White Women in Maryland Receive Different Treatment for Cervical Cancer

Por Fleming, Saroj, Schluterman, Nicholas H., Tracy, J. Katthleen, Temkin, Sarah M.
Publicado em 2014

The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years

Por Gibson, Steven J., Fleming, Gini F., Temkin, Sarah M., Chase, Dana M.
Publicado no Front Oncol (2016)

Reducing Overtreatment in Gynecologic Oncology: The Case for Less in Endometrial and Ovarian Cancer

Por Temkin, Sarah M., Tanner, Edward J., Dewdney, Summer B., Minasian, Lori M.
Publicado no Front Oncol (2016)

Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future

Por Fields, Emma C., McGuire, William P., Lin, Lilie, Temkin, Sarah M.
Publicado no Front Oncol (2017)

Serial Sectioning of the Fallopian Tube Allows for Improved Identification of Primary Fallopian Tube Carcinoma

Por Lengyel, Ernst, Fleming, Saroj, McEwen, Kelsey A, Montag, Anthony, Temkin, Sarah M.
Publicado em 2012

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons

Por Majithia, Neil, Temkin, Sarah M., Ruddy, Kathryn J., Beutler, Andreas S., Hershman, Dawn L., Loprinzi, Charles L.
Publicado no Support Care Cancer (2015)

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: The role of individual-level and contextual social determinants

Por Moss, Jennifer L., Murphy, Jeanne, Filiaci, Virginia L., Wenzel, Lari B., Minasia, Lori, Temkin, Sarah M.
Publicado no Support Care Cancer (2018)

Fatty acid oxidation: An emerging facet of metabolic transformation in cancer

Por Ma, Yibao, Temkin, Sarah M., Hawkridge, Adam M., Guo, Chunqing, Wang, Wei, Wang, Xiang-Yang, Fang, Xianjun
Publicado no Cancer Lett (2018)

Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

Por Ma, Yibao, Wang, Wei, Idowu, Michael O., Oh, Unsong, Wang, Xiang-Yang, Temkin, Sarah M., Fang, Xianjun
Publicado no Cancers (Basel) (2018)

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer

Por Rubinsak, Lisa A., Terplan, Mishka, Martin, Caitlin E., Fields, Emma C., McGuire, William P., Temkin, Sarah M.
Publicado no Gynecol Oncol Rep (2019)

Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models

Por Wise, Hannah C., Iyer, Gopakumar V., Moore, Kathleen, Temkin, Sarah M., Gordon, Sarah, Aghajanian, Carol, Grisham, Rachel N.
Publicado no Sci Rep (2019)

VEGF potentiates GD3-mediated immune suppression by human ovarian cancer cells

Por Tiper, Irina V., Temkin, Sarah M., Spiegel, Sarah, Goldblum, Simeon E., Giuntoli, Robert L., Oelke, Mathias, Schneck, Jonathan P., Webb, Tonya J.
Publicado no Clin Cancer Res (2016)

Assessing Gynecologic and Breast Cancer Survivors’ Sexual Health Care Needs (Sexual Care Needs of Cancer Survivors)

Por Hill, Emily K., Sandbo, Stacey, Abramsohn, Emily, Makelarski, Jennifer, Wroblewski, Kristen, Wenrich, Emily Rose, McCoy, Stacy, Temkin, Sarah M., Yamada, S. Diane, Lindau, Stacy Tessler
Publicado em 2010

Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer

Por Xu, Zhaomin, Becerra, Adan Z., Justiniano, Carla F., Aquina, Christopher T., Fleming, Fergal J., Boscoe, Francis P., Schymura, Maria J., Sinno, Abdulrahman K., Chaoul, Jessica, Morrow, Gary R., Minasian, Lori, Temkin, Sarah M.
Publicado no J Surg Res (2019)

Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease

Por Wright, Jason D., Cui, Rosa R., Wang, Anqi, Chen, Ling, Tergas, Ana I., Burke, William M., Ananth, Cande V., Hou, June Y., Neugut, Alfred I., Temkin, Sarah M., Wang, Y. Claire, Hershman, Dawn L.
Publicado no J Natl Cancer Inst (2015)

Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-grade Serous Carcinoma: A Review of the Evidence

Por Sherman, Mark E., Drapkin, Ronny I., Horowitz, Neil S., Crum, Christopher P., Friedman, Sue, Kwon, Janice, Levine, Douglas A., Shih, Ie-Ming, Shoupe, Donna, Swisher, Elizabeth M., Walker, Joan, Trabert, Britton, Greene, Mark H., Samimi, Goli, Temkin, Sarah M., Minasian, Lori M.
Publicado no Cancer Prev Res (Phila) (2016)

Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis ()

Por Fader, Amanda N., Java, James, Tenney, Meaghan, Ricci, Stephanie, Gunderson, Camille C., Temkin, Sarah M., Spirtos, Nick, Kushnir, Christina L., Pearl, Michael L., Zivanovic, Oliver, Tewari, Krishnansu S., O'Malley, David, Hartenbach, Ellen M., Hamilton, Chad A., Gould, Natalie S., Mannel, Robert S., Rodgers, William, Walker, Joan L.
Publicado no Gynecol Oncol (2016)